News + Filings Transactions Holdings
|
ORBIMED ADVISORS LLC
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/03/2023 | NeuroPace Inc | NPCE | Sale | Common Stock | 700 | $9.02 | $6.3k | See Footnotes | 10/02/2023 |
| 10/02/2023 | NeuroPace Inc | NPCE | Sale | Common Stock | 7.6k | $9.08 | $69.1k | See Footnotes | 10/02/2023 |
| 08/15/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 535.5k | $0.75 | $401.7k | See footnotes | 08/15/2023 |
| 08/15/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 248.8k | $0.75 | $186.6k | See footnotes | 08/15/2023 |
| 08/15/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 38.3k | $0.75 | $28.7k | See footnotes | 08/15/2023 |
| 07/31/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 26.6k | $3.00 | $79.9k | See footnotes | 07/31/2023 |
| 07/31/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 29.7k | $3.00 | $89.1k | See footnotes | 07/31/2023 |
| 07/31/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 153.1k | $3.00 | $459.2k | See footnotes | 07/31/2023 |
| 07/25/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 7.8k | $2.92 | $22.8k | See footnotes | 07/25/2023 |
| 07/25/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 4.7k | $2.92 | $13.7k | See footnotes | 07/25/2023 |
| 07/25/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 26.7k | $2.92 | $78k | See footnotes | 07/25/2023 |
| 07/13/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 9.8k | $2.40 | $23.5k | See footnotes | 07/13/2023 |
| 07/13/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 52.8k | $2.40 | $126.7k | See footnotes | 07/13/2023 |
| 07/13/2023 | Galecto, Inc. | GLTO | Sale | Common Stock | 132.1k | $2.40 | $317k | See footnotes | 07/13/2023 |
| 06/28/2023 | Passage BIO, Inc. | PASG | Purchase | Common Stock | 575.2k | $0.84 | $483.2k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 125k | $2.09 | $261.2k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 250k | $2.09 | $522.5k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 442k | $2.09 | $923.8k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 58k | $2.09 | $121.2k | See footnotes | 06/27/2023 |
| 06/27/2023 | Passage BIO, Inc. | PASG | Purchase | Common Stock | 617.4k | $0.84 | $518.6k | See footnotes | 06/27/2023 |
| 05/22/2023 | Prelude Therapeutics Inc | PRLD | Purchase | Common Stock | 869.6k | $5.75 | $5M | See footnotes | 05/22/2023 |
| 05/17/2023 | Enliven Therapeutics, Inc. | IMRA | Exercise | Stock Options (Right to Buy) | 2.1k | $4.28 | $9.1k | See footnotes | 05/17/2023 |
| 05/15/2023 | Verona Pharma plc | VRNA | Sale | Ordinary Shares | 14.4k | $21.96 | $316.2k | See footnotes | 05/11/2023 |
| 05/15/2023 | Verona Pharma plc | VRNA | Sale | Ordinary Shares | 345.3k | $20.00 | $6.9M | See footnotes | 05/11/2023 |
| 05/12/2023 | Verona Pharma plc | VRNA | Sale | Ordinary Shares | 43.2k | $21.64 | $934.8k | See footnotes | 05/11/2023 |
| 05/11/2023 | Verona Pharma plc | VRNA | Sale | Ordinary Shares | 80k | $22.26 | $1.8M | See footnotes | 05/11/2023 |
| 05/05/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 490.5k | $2.82 | $1.4M | See footnotes | 05/04/2023 |
| 05/05/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 490.5k | $2.82 | $1.4M | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 83.5k | $2.75 | $229.5k | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 313k | $2.75 | $860.7k | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 83.5k | $2.75 | $229.5k | See footnotes | 05/04/2023 |
| 02/23/2023 | Enliven Therapeutics, Inc. | IMRA | Grant | Common Stock | 7.6M | $0.00 | $0 | See footnotes | 02/23/2023 |
| 02/23/2023 | Enliven Therapeutics, Inc. | IMRA | Grant | Common Stock | 288.1k | $0.00 | $0 | See footnotes | 02/23/2023 |
| 02/17/2023 | Kinnate Biopharma Inc. | | Grant | Common Stock | 550k | $0.00 | $0 | See footnotes | 02/17/2023 |
| 02/17/2023 | Kinnate Biopharma Inc. | | Grant | Common Stock | 550k | $0.00 | $0 | See footnotes | 02/17/2023 |
|
|